Publications

ORDER ONLINE  •  CALL 866.753.0747  •  FAX 678.753.0746

Tau Citations

2017

Chloe K. Nobuhara, Sarah L. DeVos, Caitlin Commins, Susanne Wegmann, Benjamin D. Moore, Allyson D. Roe, Isabel Costantino, Matthew P. Frosch, Rose Pitstick, George A. Carlson (2017) Tau Antibody–Targeting Pathological Species Block Neuronal Uptake and Interneuron Propagation of Tau in Vitro. Science Direct Pathology; http://doi.org/10.1016/j.ajpath.2017.01.022.
Richard RubensteinEmail author, Binggong Chang, Natalia Grinkina, Eleanor Drummond, Peter Davies, Meir Ruditzky, Deep Sharma, Kevin Wang and Thomas Wisniewski (2017) Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. BioMed Central; 10.1186/s40478-017-0435-7.

2016

Kathleen M. Schoch, Sarah L. DeVos, Rebecca L. Miller,Seung J. Chun, Michaela Norrbom, David F.Wozniak, Hana N. Dawson, C. Frank Bennett, Frank Rigo,and Timothy M. Miller (2016) Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model. Semantic Scholar Neuron, Volume 90; .
Yannick Kronimus, Alexandra Albus, Monika Balzer-Geldsetzer, Sarah Straub, Elisa Semler, Markus Otto, Jens Klotsche, Richard Dodel ,LANDSCAPE Consortium ,David Mengel (2016) Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia. PLOS ONE; http://dx.doi.org/10.1371/journal.pone.0164953.
Andrew G. Hughson ,Brent Race ,Allison Kraus,Laura R. Sangaré,Lori Robins,Bradley R. Groveman,Eri Saijo,Katie Phillips,Luis Contreras,Virkamal Dhaliwal,Matteo Manca,Gianluigi Zanusso,Daniel Terry,Jeffrey F. Williams, Byron Caughey (2016) Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid. Plos.org; http://dx.doi.org/10.1371/journal.ppat.1005914.
Tomohiro Umeda, Kenjiro Ono, Ayumi Sakai, Minato Yamashita, Mineyuki Mizuguchi, William L. Klein, Masahito Yamada, Hiroshi Mori, Takami Tomiyama (2016) Rifampicin is a candidate preventive medicine against amyloid β and tau oligomers. Oxford University Press; DOI: http://dx.doi.org/10.1093/brain/aww042.

2015

Hirohide Asai, Seiko Ikezu, Satoshi Tsunoda, Maria Medalla, Jennifer Luebke, Tarik Haydar, Benjamin Wolozin, Oleg Butovsky, Sebastian Kügler & Tsuneya Ikezu (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nature; doi:10.1038/nn.4132.
Lenka Hromadkova, Michala Kolarova, Barbora Jankovicova, Ales Bartos, Jan Ricny, Zuzana Bilkova, Daniela Ripova (2015) Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product. Science Direct; doi:10.1016/j.jneuroim.2015.10.017.
Nitsch, Roger; Chen, Feng; Grimm, Jan; Baeriswyl, Jean-luc; Hock, Christoph (2015) HUMAN ANTI-TAU ANTIBODIES. Free Patents Online; http://www.freepatentsonline.com/y2015/0252102.html.
Mcavoy, Thomas, Lassman, Michael E., Laterza, Omar F. (2015) QUANTIFICATION OF TAU IN BIOLOGICAL SAMPLES BY IMMUNOAFFINITY ENRICHMENT AND MASS SPECTROMETRY. Free Patents Online; http://www.freepatentsonline.com/y2015/0253341.html.
Pawel Tacik , Michael DeTure , Wen-Lang Lin, Monica Sanchez Contreras, Aleksandra Wojtas, Kelly M. Hinkle, Shinsuke Fujioka, Matthew C. Baker, Ronald L. Walton , Yari Carlomagno, Patricia H. Brown, Audrey J. Strongosky, Naomi Kouri, Melissa E. Murray, Leonard Petrucelli, Keith A. Josephs, Rosa Rademakers, Owen A. Ross, Zbigniew K. Wszolek, Dennis W. Dickson (2015) A novel tau mutation, p.K317N, causes globular glial tauopathy. Springer Link; doi:10.​1007/​s00401-015-1425-0.
B. Michalski, M.M. Corrada, C.H. Kawas, M. Fahnestock (2015) Brain-derived neurotrophic factor and TrkB expression in the “oldest-old,” the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta. ScienceDirect; doi:10.1016/j.neurobiolaging.2015.08.022.
David A. Loeffler, Lynnae M. Smith, Andrea C. Klaver, Sanela Martić (2015) Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report. ScienceDirect; doi:10.1016/j.exger.2015.04.010.
Ann De Vos , Dirk Jacobs , Hanne Struyfs , Erik Fransen , Kerstin Andersson , Erik Portelius , Ulf Andreasson , Didier De Surgeloose , Daniëlle Hernalsteen , Kristel Sleegers , Caroline Robberecht , Christine Van Broeckhoven , Henrik Zetterberg , Kaj Blennow , Sebastiaan Engelborghs , Eugeen Vanmechelen (2015) C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. The Journal of the Alzheimer's Association; doi.org/10.1016/j.jalz.2015.05.012.
Sethu Sankaranarayanan, Donna M. Barten, Laurel Vana, Nino Devidze, Ling Yang, Gregory Cadelina, Nina Hoque, Lynn DeCarr, Stefanie Keenan, Alan Lin, Yang Cao, Bradley Snyder, Bin Zhang, Magdalena Nitla, Gregg Hirschfeld, Nestor Barrezueta, Craig Polson, Paul Wes, Vangipuram S. Rangan, Angela Cacace, Charles F. Albright, Jere Meredith Jr., John Q. Trojanowski, Virginia M-Y. Lee,Kurt R. Brunden, Michael Ahlijanian (2015) Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models. PLOS One; DOI: 10.1371/journal.pone.0125614.
Miranda E. Orr, Valentina R. Garbarino, Angelica Salinas, Rochelle Buffenstein (2015) Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent. ScienceDirect; doi:10.1016/j.neurobiolaging.2014.12.004.
Jessica Bright, Sami Hussain, Vu Dang, Sarah Wright, Bonnie Cooper, Tony Byun, Carla Ramos, Andrew Singh, Graham Parry, Nancy Stagliano, Irene Griswold-Prenner (2015) Human secreted tau increases amyloid-beta production. ScienceDirect; doi:10.1016/j.neurobiolaging.2014.09.007.
Kiran Yanamandra, Hong Jiang, Thomas E. Mahan, Susan E. Maloney, David F. Wozniak, Marc I. Diamond and David M. Holtzman (2015) Anti-tau antibody reduces insoluble tau and decreases brain atrophy. Wiley Online Library; DOI: 10.1002/acn3.176.
Jose O. Esteves-Villanueva, Hanna Trzeciakiewicz, David A. Loeffler, and Sanela Martić (2015) Effects of Tau Domain-Specific Antibodies and Intravenous Immunoglobulin on Tau Aggregation and Aggregate Degradation. ACS Publications; DOI: 10.1021/bi501272x.
Subramaniyan, S.P.; Tarhan, M.C.; Karsten, S.L.; Fujita, H.; Shintaku, H.; Kotera, H.; Yokokawa, R. (2015) On-chip detection of wild 3R, 4R and mutant 4R tau through kinesin-microtubule binding. IEEE Xplore; doi: 10.1109/MEMSYS.2015.7050988.

2014

Miranda E. Orr, Valentina R. Garbarino, Angelica Salinas, Rochelle Buffenstein (2014) Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent. Neurobiology of Aging; DOI: http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.004.
Joëlle Rosseels, Jeff Van den Brande, Marie Violet, Dirk Jacobs, Pierre Grognet, Juan Lopez, Isabelle Huvent, Marina Caldara, Erwin Swinnen, Anthony Papegaey, Raphaëlle Caillierez, Valerie Buée-Scherrer, Sebastiaan Engelborghs, Guy Lippens, Morvane Colin, Luc Buée, Marie-Christine Galas, Eugeen Vanmechelen and Joris Winderickx (2014) Tau Monoclonal Antibody Generation based on Humanized Yeast Models: Impact on Tau Oligomerization and Diagnostics.. The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.627919.
Daniel Paris, Ghania Ait-Ghezala, Corbin Bachmeier, Gary Laco, David Beaulieu-Abdelahad, Yong Lin, Chao Jin, Fiona Crawford and Michael Mullan (2014) The Spleen Tyrosine Kinase (syk) Regulates Alzheimer's Aβ Production and Tau Hyperphosphorylation. The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.608091.
Snow, Alan D.; Hu, Qubai; Lake, Thomas; Cam, Judy (2014) Compounds and Compositions for use a Modulators of Tau Aggregation and Alleviation of Tauopathies. FPO; .
Lynnae M. Smith, Mary P. Coffey, David A. Loeffler (2014) Specific binding of intravenous immunoglobulin products to tau peptide fragments. Science Direct; doi:10.1016/j.intimp.2014.05.009.
Lynnae M. Smitha, Mary P. Coffeyb, David A. Loeffler (2014) Specific binding of intravenous immunoglobulin products to tau peptide fragments. Science Direct; http://dx.doi.org/10.1016/j.intimp.2014.05.009.
Thomas McAvoy, Michael E. Lassman, Daniel S. Spellman, Zhenlian Ke, Bonnie J. Howell, Oitak Wong, Lan Zhu, Michael Tanen, Arie Struyk, and Omar F. Laterza (2014) Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry. Clinical Chemistry; doi: 10.1373/clinchem.2013.216515.

2013

Astrid Gumucio, Lars Lannfelt, and Lars NG Nilsson (2013) Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging. BMC Neuroscience; doi:10.1186/1471-2202-14-148.
Jere E. Meredith Jr., Sethu Sankaranarayanan, Valerie Guss, Anthony J. Lanzetti, Flora Berisha, Robert J. Neely, J. Randall Slemmon, Erik Portelius, Henrik Zetterberg, Kaj Blennow, Holly Soares, Michael Ahlijanian, Charles F. Albright (2013) Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease. PLoS One; DOI: 10.1371/journal.pone.0076523.
Jean-Marie Sontag, Viyada Nunbhakdi-Craig, and Estelle Sontag (2013) Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells. The Journal of Biological Chemistry; doi: 10.1074/jbc.M113.490102.
Georges Mairet-Coello, Julien Courchet, Simon Pieraut, Virginie Courchet, Anton Maximov, and Franck Polleux (2013) The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Ab Oligomers through Tau Phosphorylation. Cell Press; .
Karla I. Lira-De León, Ponciano García-Gutiérrez, Iris N. Serratos, Marianela Palomera-Cárdenas, María del P. Figueroa-Corona, Victoria Campos-Peña, Marco A. Meraz-Ríos (2013) Molecular Mechanism of Tau Aggregation Induced by Anionic and Cationic Dyes. IOS Press; DOI: 10.3233/JAD-121765 (Pay to View).
Stefanie Karen Forest (2013) Immunotherapy targeting tau pathology-studies in an hTau mouse model. umi.com; Publication Number 3535073.
Karla I. Lira-De Leo ́n, Ponciano Garc ́ıa-Gutie ́rrez,Iris N. Serratos, Marianela Palomera-Ca ́rdenas, Mar ́ıa del P. Figueroa-Corona, Victoria Campos-Pen ̃a, Marco A. Meraz-R ́ıos (2013) Molecular Mechanism of Tau Aggregation Induced by Anionic and Cationic Dyes. IOS Press; DOI 10.3233/JAD-121765.
Christopher M. Acker, Stefanie K. Forest, Ray Zinkowski, Peter Davies, Cristina d'Abramo (2013) Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models. Elsevier Inc.; doi:10.1016/j.neurobiolaging.2012.05.010.

2012

Josef Pannee, Erik Portelius, Madalina Oppermann, Alan Atkins, Martin Hornshaw, Ingrid Zegers, Peter Höjrup, Lennart Minthon, Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Johan Gobom (2012) A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A38, A40, and A42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls. IOS Press; DOI: 10.3233/JAD-2012-121471.
Forest SK, Acker CM, d'Abramo C, Davies P. (2012) Methods for Measuring Tau Pathology in Transgenic Mouse Models. IOS Press; DOI 10.3233/JAD-2012-121354, PMID: 22976073 (Pay to View).
Chai, X., Dage, J.L., Citron, M. (2012) Constitutive secretion of tau protein by an unconventional mechanism. Neurobiology of Disease; Available online 2 June 2012 DOI 10.1016/j.nbd.2012.05.021.
Acker, C.M., Forest, S.K., Zinkowski, R., Davies, P., d’Abramco, C. (2012) Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.. Neurobiology of Aging; Volume 33, Issue 8, Pages 1493-1856 (August 2012) DOI 10.1016/j.neurobiolaging.2012.05.010.
Nitsch, R, Chen, F , Grimm, J , Baeriswyl, J , Hock, C. (2012) Human Anti-Tau Antibodies.. United States Patent Application 20120087861;; 2012 Apr 12; DOI: y2012/0087861.html.
Madampage, C., Tavassoly, O., Christensen, C., Kumari, M., Lee, J.S. (2012) Nanopore Analysis: An emerging technique for studying the folding and misfolding of proteins.. Prion; 2012 Apr 1;6(2):116-23. Epub 2012 Apr 1.pp 116-123 DOI /10.4161/pri.18665.
Nakamura, K., Greenwood, A., Binder, L., Bigio, EH, Denial, S, Nicholson, L., Zhou, XZ, Lu, KP (2012) Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease.. Cell; Volume 149, Issue 1, 232-244, 2012 March 30 DOI: 10.1016/j.cell.2012.02.016.
Saman, S., Kim, W, Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, AC, Alvarez, VE, Lee, NC and Hall, GF. (2012) Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease.. The Journal of Biological Chemistry; 2012 Feb 3; The Journal of Biological Chemistry, 287, 3842-3849. doi: 10.1074/jbc.M111.277061.
Wilhelmus, M. M., de Jager, M., Rozemuller, A. J., Brevé, J., Bol, J. G., Eckert, R. L. and Drukarch, B., (2012) Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.. J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.

2011

Chai, X., Wu, S., Murray, T., Kinley, R, Cella, C., Sims, H., Buckner, N., Hanmer, J., Davies, P., O'Neill, M, .Hutton, M.and Citron, M. (2011) Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models. The Journal of Biological Chemistry; 2011 Sept 30 The Journal of Biological Chemistry, 286, 34457-34467.2011 Aug 12, doi: 10.1074/jbc.M111.229633..
Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, Ward S, Reyes JF, Philibert K, Glucksman MJ, Binder LI. (2011) Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem; 2011 Jul 1;286(26):23063-76. Epub 2011 May 6; PMID: 21550980; PMCID: PMC3123074.
Snow, A. , Hu, Q., Lake, T. (2011) Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies. United States Patent Application; United States Patent Application 20110144124; 2011 June 16; DOI: y2011/0144124.html.
Barten, D.M, Cadelina, G.W., Hoque, N., DeCarr, L.B., Guss, V. L., Yang, L., Sankaranarayanan, S., Wes, P.D., Flynn, M. E., Meredith, J, Ahlijanian, M., Albright, C. (2011) Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers. Journal of Alzheimer's Disease; Volume 24, Supplement 2/ 2011 Mar 18 DOI: 10.3233/JAD-2011-110161.

2010

Sontag JM, Nunbhakdi-Craig V, Mitterhuber M, Ogris E, Sontag E. (2010) Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells. J Neurochem; 2010 Dec;115(6):1455-65. doi: 10.1111/j.1471-4159.2010.07049.x..
Spicakova T, O'Brien MM, Duran GE, Sweet-Cordero A, Sikic BI. (2010) Expression and silencing of the microtubule-associated protein Tau in breast cancer cells. Mol Cancer Ther; 2010 Nov; 9 (11) :2970-81. PubMed PMID:21062914..
Eroglu B, Moskophidis D, Mivechi NF. (2010) Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta. Mol Cell Biol.; 2010 Oct; 30 (19) :4626-43. PubMed PMID:20679486; PubMed Central PMCID: PMC2950521..
Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, Meyers D, Cole PA, Ott M, Gan L. (2010) Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy. Neuron; 2010 Sep 23;67(6):953-66. Doi 10.1016/j.neuron.2010.08.044.
Padmaraju V, Indi SS, Rao KS. (2010) New evidences on Tau-DNA interactions and relevance to neurodegeneration. Neurochem Int; 2010 Aug; 57 (1) :51-7. PubMed PMID:20435075..
Bohoyo D, Le Potier I, Rivière C, Klafki H, Wiltfang J, Taverna M. (2010) A quantitative CE method to analyse tau protein isoforms using coated fused silica capillaries. J Sep Sci.; 2010 Apr; 33 (8) :1090-8. PubMed PMID:20187030..
Bailey JA, Lahiri DK. (2010) A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease. J Neurochem; 2010 Feb; 112 (4) :843-53. PubMed PMID:19912467; PubMed Central PMCID: PMC2881332..
Li Y, Duffy KB, Ottinger MA, Ray B, Bailey JA, Holloway HW, Tweedie D, Perry T, Mattson MP, Kapogiannis D, Sambamurti K, Lahiri DK, Greig NH. (2010) GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease. J Alzheimers Dis; 2010;19(4):1205-19. DOI 10.3233/JAD-2010-1314.
Tremblay MA, Acker CM, Davies P. (2010) Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase. Arg. J Alzheimers Dis; 2010; 19 (2) :721-33. PubMed PMID:20110615..

2009

Ray B, Bailey JA, Sarkar S, Lahiri DK. (2009) Molecular and immunocytochemical characterization of primary neuronal cultures from adult rat brain: Differential expression of neuronal and glial protein markers. J Neurosci Methods; 2009 Nov 15;184(2):294-302. Epub 2009 Aug 29. PubMed PMID: 19720084..
Luk C, Giovannoni G, Williams DR, Lees AJ, de Silva R (2009) Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies. J Neurosci Methods; 2009 May 30;180(1):34-42. Epub 2009 Mar 5. PubMed PMID: 19427527..
Momeni P, Pittman A, Lashley T, Vandrovcova J, Malzer E, Luk C, Hulette C, Lees A, Revesz T, Hardy J, de Silva R. (2009) Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation. Neurobiol Aging; 2009 Mar;30(3):388-93. Epub 2007 Aug 27. PubMed PMID: 17723255; PubMed Central PMCID: PMC2666148..

2008

Kovacs GG, Pittman A, Revesz T, Luk C, Lees A, Kiss E, Tariska P, Laszl, L, Molnár KJ. Molnar MJ, et al. (2008) MAPT S305I mutation: implications for argyrophilic grain disease. Acta Neuropathol; 2008 Jul;116(1):103-18. Epub 2007 Dec 8.
Hübinger, G., Geis, S., LeCorre, S., Mühlbacher, S., Gordon, S., Fracasso, R.P., Hoffman, F ., Ferrand, S ., Klafki, H.W ., Roder, H.M . (2008) Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a. Journal of Alzheimer's Disease; 13(3): 281-294..
Skoglund, L., Viitanen, M., Kalimo, H., Lannfelt, L., Ingelsson, M., Glaser, A., Herva, R. (2008) The tau S305S mutation causes frontotemporal dementia with parkinsonism. European Journal of Neurology; 15(2): 156-161..